Markets · News reference
Filed: 2026-07-21 AccNo: 0001193125-26-309602 Size: 468 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
No ticker was attached by the source feed.
Keep reading
On August 21, 2026, Satellogic Inc. (the "Company") appointed Dustin Greer as Interim Chief Financial Officer ("Interim CFO"), effective immediately. Mr. Greer also serves as the Company’s principal
Read original at benzinga-Conference Call
Read original at benzingaHere's a detailed look inside the Q4 earnings report from Affirm.
Read original at benzingaAffirm Holdings (NASDAQ:AFRM) FY2027 Revenue expected to be more than $5.440B vs $5.287B Est. GMV Expected at More Than $64 Billion; Revenue/GMV Ratio Seen at 8.5%.
Read original at benzingaBitcoin rally driven by spot demand and spreading to altcoins. Bitfinex sees $80,000 as key resistance. Nineteen altcoins gain over 12%.
Read original at benzingaThe global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.
Read original at globenewswire-inc